Typically, low-grade serous ovarian carcinoma has few somatic mutations, which are mainly found in genes associated with the mitogen-activated protein kinase pathway such as KRAS, BRAF and NRAS [23, 25, 28]. Here, KRAS is linked to ovarian serous carcinoma.